Advanced Stage Hodgkin Lymphoma clinical trials

Explore recruiting advanced stage hodgkin lymphoma clinical trials.

Recruiting advanced stage hodgkin lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Stage Hodgkin Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EORTC-1537-LYMG: Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study

Denmark, Portugal, Spain, Poland, Slovakia, Belgium +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

HD21 for advanced stages - Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD

Norway, Austria, Netherlands, Germany, Denmark, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advanced Stage Hodgkin Lymphoma trials by city

Advanced Stage Hodgkin Lymphoma clinical trials

Recruiting advanced stage hodgkin lymphoma studies right now

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

A Study of NX-1607 in Adults With Advanced Malignancies

A Phase I Study of JLM019 Injection

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer

Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma

Evaluate the Safety and Clinical Activity of HH2853

Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

Also recruiting in Europe

EORTC-1537-LYMG: Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study

HD21 for advanced stages - Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD

Advanced Stage Hodgkin Lymphoma trials by city

Other conditions